Global Follicle Stimulating Hormone Market 2017 report spread across 115 pages gives Market Segment Analysis by Key Manufacturers, Countries, Types and Applications. Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles. In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU.
Scope of the Report:
This report focuses on the Global Follicle Stimulating Hormone market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers: Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci.
Market Segment by Regions, regional analysis covers: North America (USA, Canada and Mexico); Europe (Germany, France, UK, Russia and Italy); Asia-Pacific (China, Japan, Korea, India and Southeast Asia); South America (Brazil, Argentina, Columbia etc.); Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). Market Segment by Type, covers: Recombinant FSH, Urinary FSH & Market Segment by Applications, can be divided into: Infertility Treatment, Assisted Reproductive Technology.
Request for discount at
There are 15 Chapters to deeply display the global Follicle Stimulating Hormone market.
Chapter 1 to describe Follicle Stimulating Hormone Introduction, product scope, market overview, market opportunities, market risk, market driving force.
Chapter 2 to analyze the top manufacturers of Follicle Stimulating Hormone, with sales, revenue, and price of Follicle Stimulating Hormone, in 2016 and 2017.
Chapter 3 to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017.
Chapter 4 to show the global market by regions, with sales, revenue and market share of Follicle Stimulating Hormone, for each region, from 2012 to 2017.
Chapter 5, 6, 7, 8 and 9 to analyze the key regions, with sales, revenue and market share by key countries in these regions.
Order copy of report at
Chapter 10 and 11 to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017.
Chapter 12 Follicle Stimulating Hormone market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022.
Chapter 13, 14 and 15 to describe Follicle Stimulating Hormone sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.